Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Focal Lipoid Glomerulosclerosis”

43 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 43 results

Large-scale testing (Phase 3)Looking for participantsNCT07499700
What this trial is testing

A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis

Who this might be right for
Minimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)
Bio-Thera Solutions 192
Not applicableLooking for participantsNCT03929887
What this trial is testing

KOrea Renal Biobank NEtwoRk System TOward NExt-generation Analysis

Who this might be right for
Glomerular DiseaseMinimal Change DiseaseIgA Nephropathy+4 more
Seoul National University Hospital 3,000
Large-scale testing (Phase 3)UnknownNCT03298698
What this trial is testing

Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome

Who this might be right for
Idiopathic Nephrotic SyndromeMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Radboud University Medical Center 40
Not applicableStudy completedNCT00255398
What this trial is testing

Kidney Disease Biomarkers

Who this might be right for
Kidney DiseaseGlomerular DiseaseIdiopathic Nephrotic Syndrome+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25
Early research (Phase 1)Study completedNCT05314231
What this trial is testing

Safety and Pharmacokinetic Study of Subcutaneous ALXN1720 in Participants With Proteinuria

Who this might be right for
Proteinuria
Alexion Pharmaceuticals, Inc. 13
Testing effectiveness (Phase 2)Ended earlyNCT05441826
What this trial is testing

Efficacy and Safety of VB119 in Subjects With Minimal Change Disease (MCD) and Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Minimal Change DiseaseFocal Segmental Glomerulosclerosis
Tenet Medicines 1
Testing effectiveness (Phase 2)Looking for participantsNCT06500702
What this trial is testing

Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisGlomerulonephritis Minimal Lesion
Sanofi 84
Not applicableLooking for participantsNCT05583942
What this trial is testing

A Pilot Trial of taVNS for SRNS in Children (kidNEY-VNS)

Who this might be right for
Nephrotic Syndrome in ChildrenMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Northwell Health 10
Testing effectiveness (Phase 2)Ended earlyNCT04950114
What this trial is testing

An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases

Who this might be right for
Kidney DiseasesGlomerulosclerosisFocal Segmental Nephrosis+4 more
Goldfinch Bio, Inc. 31
Not applicableLooking for participantsNCT05588063
What this trial is testing

TaVNS for FRNS in Children

Who this might be right for
Nephrotic Syndrome in ChildrenMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Northwell Health 30
Not applicableLooking for participantsNCT05650619
What this trial is testing

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseFSGS+1 more
University of Michigan 300
Not applicableLooking for participantsNCT07010250
What this trial is testing

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

Who this might be right for
ANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more
Assistance Publique - Hôpitaux de Paris 146
Not applicableLooking for participantsNCT05505500
What this trial is testing

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

Who this might be right for
Fluid OverloadGlomerulosclerosis, Focal SegmentalEdema+10 more
University of Michigan 150
Testing effectiveness (Phase 2)Ended earlyNCT04387448
What this trial is testing

TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis, and Treatment-Resistant Minimal Change Disease

Who this might be right for
Kidney DiseasesDiabetic NephropathiesGlomerulosclerosis, Focal Segmental+8 more
Goldfinch Bio, Inc. 96
Not applicableStudy completedNCT07702981
What this trial is testing

Immunophenotyping Profiling in Patients With Primary Nephrotic Syndrome

Who this might be right for
Membranous NephropathyMinimal Change Disease (MCD)Focal Segmental Glomerulosclerosis (FSGS)
University Hospital, Ioannina 40
Not applicableActive Not RecruitingNCT02194582
What this trial is testing

Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure

Who this might be right for
Focal Segmental GlomerulosclerosisNephrotic SyndromeEnd Stage Renal Disease+2 more
Beth Israel Deaconess Medical Center 2,050
Large-scale testing (Phase 3)Active Not RecruitingNCT06635720
What this trial is testing

REduced-dose Steroid PrOtocol for Childhood Nephrotic SyndromE (RESPONSE)

Who this might be right for
Nephrotic Syndrome in ChildrenNephrotic Syndrome, Minimal ChangeNephrotic Syndrome+1 more
The Hospital for Sick Children 50
Not applicableUnknownNCT06443034
What this trial is testing

Predictive Determinants of Nephrotic Syndrome Remission in Patients With At-risk Polymorphism of APOL1

Who this might be right for
Nephrotic SyndromeFocal Segmental GlomerulosclerosisAPOL1 Associated Kidney Disease
Assistance Publique - Hôpitaux de Paris 124
Not applicableLooking for participantsNCT05036850
What this trial is testing

China Kidney Patient Trials Network

Who this might be right for
Kidney Diseases
George (Beijing) Clinical Research Co. Ltd. 1,200
Not applicableStudy completedNCT04369183
What this trial is testing

Rituximab for Refractory or Relapsed Focal Segmental Glomerulosclerosis or Minimal Change Disease

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change Disease
Istanbul University 25
Next Page